Cargando…

An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study

BACKGROUND: Limited real-world data are currently available on hypoglycemia in diabetes patients. The International Operations Hypoglycemia Assessment Tool (IO HAT) study was designed to estimate hypoglycemia in insulin-treated type I (T1DM) and type II (T2DM) diabetes mellitus patients from 9 count...

Descripción completa

Detalles Bibliográficos
Autores principales: Emral, Rıfat, Tetiker, Tamer, Sahin, Ibrahim, Sari, Ramazan, Kaya, Ahmet, Yetkin, İlhan, Cil, Sefika Uslu, Tütüncü, Neslihan Başcıl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809967/
https://www.ncbi.nlm.nih.gov/pubmed/29433560
http://dx.doi.org/10.1186/s12902-018-0238-2
_version_ 1783299655713423360
author Emral, Rıfat
Tetiker, Tamer
Sahin, Ibrahim
Sari, Ramazan
Kaya, Ahmet
Yetkin, İlhan
Cil, Sefika Uslu
Tütüncü, Neslihan Başcıl
author_facet Emral, Rıfat
Tetiker, Tamer
Sahin, Ibrahim
Sari, Ramazan
Kaya, Ahmet
Yetkin, İlhan
Cil, Sefika Uslu
Tütüncü, Neslihan Başcıl
author_sort Emral, Rıfat
collection PubMed
description BACKGROUND: Limited real-world data are currently available on hypoglycemia in diabetes patients. The International Operations Hypoglycemia Assessment Tool (IO HAT) study was designed to estimate hypoglycemia in insulin-treated type I (T1DM) and type II (T2DM) diabetes mellitus patients from 9 countries. The data from Turkey cohort are presented here. METHODS: A non-interventional study to determine the hypoglycemia incidence, retrospectively and prospectively, in Turkish T1DM and T2DM patients using a 2-part self-assessment questionnaire. RESULTS: Overall, 2348 patients were enrolled in the Turkey cohort (T1DM = 306 patients, T2DM = 2042 patients). In T1DM patients, 96.8% patients reported hypoglycemic events (Incidence rate [IR]: 68.6 events per patient-year [ppy]), prospectively, while 74.0% patients reported hypoglycemic events (IR: 51.7 events ppy), retrospectively. In T2DM patients, 95.9% patients (IR: 28.3 events ppy) reported hypoglycemic events, prospectively, while 53.6% patients (IR: 23.0 events ppy) reported hypoglycemic events, retrospectively. Nearly all patients reported hypoglycemia during the prospective period. CONCLUSIONS: This is a first patient-reported dataset on hypoglycemia in Turkish, insulin-treated diabetes patients. A high incidence of patient-reported hypoglycemia confirms that hypoglycemia remains under-estimated. Hypoglycemia increased healthcare utilization impacting patients’ quality of life. Hypoglycemia remains a common side effect with insulin-treatment and strategies to optimize therapy and reduce hypoglycemia occurrence in diabetes patients are required. TRIAL REGISTRATION: Clinicaltrials.gov, NCT02306681 (Date of registration: 12 Nov 2014; retrospectively registered). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12902-018-0238-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5809967
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58099672018-02-16 An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study Emral, Rıfat Tetiker, Tamer Sahin, Ibrahim Sari, Ramazan Kaya, Ahmet Yetkin, İlhan Cil, Sefika Uslu Tütüncü, Neslihan Başcıl BMC Endocr Disord Research Article BACKGROUND: Limited real-world data are currently available on hypoglycemia in diabetes patients. The International Operations Hypoglycemia Assessment Tool (IO HAT) study was designed to estimate hypoglycemia in insulin-treated type I (T1DM) and type II (T2DM) diabetes mellitus patients from 9 countries. The data from Turkey cohort are presented here. METHODS: A non-interventional study to determine the hypoglycemia incidence, retrospectively and prospectively, in Turkish T1DM and T2DM patients using a 2-part self-assessment questionnaire. RESULTS: Overall, 2348 patients were enrolled in the Turkey cohort (T1DM = 306 patients, T2DM = 2042 patients). In T1DM patients, 96.8% patients reported hypoglycemic events (Incidence rate [IR]: 68.6 events per patient-year [ppy]), prospectively, while 74.0% patients reported hypoglycemic events (IR: 51.7 events ppy), retrospectively. In T2DM patients, 95.9% patients (IR: 28.3 events ppy) reported hypoglycemic events, prospectively, while 53.6% patients (IR: 23.0 events ppy) reported hypoglycemic events, retrospectively. Nearly all patients reported hypoglycemia during the prospective period. CONCLUSIONS: This is a first patient-reported dataset on hypoglycemia in Turkish, insulin-treated diabetes patients. A high incidence of patient-reported hypoglycemia confirms that hypoglycemia remains under-estimated. Hypoglycemia increased healthcare utilization impacting patients’ quality of life. Hypoglycemia remains a common side effect with insulin-treatment and strategies to optimize therapy and reduce hypoglycemia occurrence in diabetes patients are required. TRIAL REGISTRATION: Clinicaltrials.gov, NCT02306681 (Date of registration: 12 Nov 2014; retrospectively registered). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12902-018-0238-2) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-13 /pmc/articles/PMC5809967/ /pubmed/29433560 http://dx.doi.org/10.1186/s12902-018-0238-2 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Emral, Rıfat
Tetiker, Tamer
Sahin, Ibrahim
Sari, Ramazan
Kaya, Ahmet
Yetkin, İlhan
Cil, Sefika Uslu
Tütüncü, Neslihan Başcıl
An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study
title An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study
title_full An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study
title_fullStr An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study
title_full_unstemmed An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study
title_short An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study
title_sort international survey on hypoglycemia among insulin-treated type i and type ii diabetes patients: turkey cohort of the non-interventional io hat study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809967/
https://www.ncbi.nlm.nih.gov/pubmed/29433560
http://dx.doi.org/10.1186/s12902-018-0238-2
work_keys_str_mv AT emralrıfat aninternationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT tetikertamer aninternationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT sahinibrahim aninternationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT sariramazan aninternationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT kayaahmet aninternationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT yetkinilhan aninternationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT cilsefikauslu aninternationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT tutuncuneslihanbascıl aninternationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT aninternationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT emralrıfat internationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT tetikertamer internationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT sahinibrahim internationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT sariramazan internationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT kayaahmet internationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT yetkinilhan internationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT cilsefikauslu internationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT tutuncuneslihanbascıl internationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy
AT internationalsurveyonhypoglycemiaamonginsulintreatedtypeiandtypeiidiabetespatientsturkeycohortofthenoninterventionaliohatstudy